k | N | Effect size | P value | 95% PI | I2 (95% CI) | ||
Hedges’ g (95% CI) | OR (95% CI) | ||||||
Depressive symptomatology | 7 | 1024 | 0.50 (0.23 to 0.76) | 0.004 | −0.06 to 1.05 | 51.1 (0 to 79.2) | |
Rater | |||||||
Clinician-rated | 4 | 420 | 0.37 (−0.04 to 0.77) | 0.064 | −0.55 to 1.28 | 38.4 (0 to 79.0) | |
Self-reported | 7 | 1024 | 0.48 (0.23 to 0.73) | 0.004 | 0.02 to 0.94 | 45.5 (0 to 77.0) | |
Follow-up | |||||||
1–12 months | 3 | 702 | 0.36 (−0.30 to 1.02) | 0.145 | −3.00 to 3.72 | 66.9 (0 to 90.5) | |
≥12 months | 3 | 702 | 0.02 (−0.09 to 0.12) | 0.579 | −0.94 to 0.98 | 0 (0 to 89.6) | |
Remission rates | |||||||
Post-treatment | 5 | 804 | 2.57 (1.71 to 3.87) | 0.003 | 1.56 to 4.22 | 0 (0 to 79.2) | |
≥6 months follow-up | 3 | 702 | 1.75 (1.21 to 2.53) | 0.023 | 0.25 to 12.42 | 0 (0 to 89.6) | |
Relapse rates | |||||||
Post-treatment | 3 | 284 | 0.17 (0.01 to 4.83) | 0.150 | * | 62.7 (0 to 89.3) | |
≥6 months follow-up | 3 | 702 | 0.46 (0.21 to 1.03) | 0.053 | 0.04 to 5.35 | 0 (0 to 89.6) |
*PI is not reported for this outcome, as the estimate is too broad to be useful given the limited number of studies and considerable heterogeneity.
PI, prediction interval.